Back to News
Market Impact: 0.35
Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue
Source: GlobeNewswire
Corporate Guidance & OutlookAnalyst Estimates
The company anticipates Q3 2026 revenue of $9.8 million to $10.0 million, approximately 45% to 47% above Bloomberg analyst consensus. The article provides no company name or additional details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.60
More News
- Levi Strauss hikes profit guidance after tariff refunds, but its sales outlook is less optimistic
- Streamex CIO Mitchell Williams sells $35,239 in company stock
- Another Micron triple? Where we agree with this wildly bullish call and where we don't
- Levi Strauss lifts annual profit outlook on tariff refunds, holiday demand
- Profound Medical stock surges 20% on raised Q3 revenue outlook
- Marvell just gave a bullish outlook. It led TD Cowen to upgrade the stock